Reply to S Eggener, M Gonzalgo and O Yossepowitch: ‘High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series’

Por Ahmed, H U, Emberton, M
Publicado em 2009

Reply to TS Clark: ‘High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series’

Por Ahmed, H U, Emberton, M
Publicado em 2009

Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities

Por Kasivisvanathan, V., Emberton, M., Ahmed, H.U.
Publicado em 2013

Acute abdomen from a Meckel lipoma

Por Ahmed, H U, Wajed, S, Krijgsman, B, Elliot, V, Winslet, M
Publicado em 2004

Acute abdomen secondary to a Meckel's lipoma.

Por Ahmed, H. U., Wajed, S., Krijgsman, B., Elliot, V., Winslet, M.
Publicado em 2004

PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer()

Por El-Shater Bosaily, A., Parker, C., Brown, L.C., Gabe, R., Hindley, R.G., Kaplan, R., Emberton, M., Ahmed, H.U.
Publicado no Contemp Clin Trials (2015)

High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series

Por Ahmed, H U, Zacharakis, E, Dudderidge, T, Armitage, J N, Scott, R, Calleary, J, Illing, R, Kirkham, A, Freeman, A, Ogden, C, Allen, C, Emberton, M
Publicado em 2009

Erratum: The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial

Por El-Shater Bosaily, A, Valerio, M, Hu, Y, Freeman, A, Jameson, C, Brown, L, Kaplan, R, Hindley, R G, Barratt, D, Emberton, M, Ahmed, H U
Publicado no Prostate Cancer Prostatic Dis (2016)

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial

Por El-Shater Bosaily, A, Valerio, M, Hu, Y, Freeman, A, Jameson, C, Brown, L, Kaplan, R, Hindley, R G, Barratt, D, Emberton, M, Ahmed, H U
Publicado no Prostate Cancer Prostatic Dis (2016)

A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study()()

Por Dickinson, L., Ahmed, H.U., Kirkham, A.P., Allen, C., Freeman, A., Barber, J., Hindley, R.G., Leslie, T., Ogden, C., Persad, R., Winkler, M.H., Emberton, M.
Publicado em 2013

PSA nadir as a predictive factor for biochemical disease-free survival and overall survival following whole-gland salvage HIFU following radiotherapy failure

Por Shah, T T, Peters, M, Kanthabalan, A, McCartan, N, Fatola, Y, van der Voort van Zyp, J, van Vulpen, M, Freeman, A, Moore, C M, Arya, M, Emberton, M, Ahmed, H U
Publicado no Prostate Cancer Prostatic Dis (2016)

Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters

Por Linch, M., Goh, G., Hiley, C., Shanmugabavan, Y., McGranahan, N., Rowan, A., Wong, Y. N. S., King, H., Furness, A., Freeman, A., Linares, J., Akarca, A., Herrero, J., Rosenthal, R., Harder, N., Schmidt, G., Wilson, G. A., Birkbak, N. J., Mitter, R., Dentro, S., Cathcart, P., Arya, M., Johnston, E., Scott, R., Hung, M., Emberton, M., Attard, G., Szallasi, Z., Punwani, S., Quezada, S. A., Marafioti, T., Gerlinger, M., Ahmed, H. U., Swanton, C.
Publicado no Ann Oncol (2017)